Items where authors include "Dubash, S"

Article

Ćorović, A, Wall, C, Nus, M et al. (40 more authors) (2023) Somatostatin Receptor PET/MR Imaging of Inflammation in Patients With Large Vessel Vasculitis and Atherosclerosis. Journal of the American College of Cardiology, 81 (4). pp. 336-354. ISSN 0735-1097

Dubash, S, Alabas, OA, Michelena, X et al. (7 more authors) (2021) Dactylitis is an indicator of a more severe phenotype independently associated with greater SJC, CRP, ultrasound synovitis and erosive damage in DMARD-naive early psoriatic arthritis. Annals of the Rheumatic Diseases. ISSN 0003-4967

Sharif, K, Bridgewood, C, Dubash, S et al. (1 more author) (2020) Intestinal and enthesis innate immunity in early axial spondyloarthropathy. Rheumatology, 59 (Supplement_4). iv67-iv78. ISSN 1462-0324

Marzo-Ortega, H orcid.org/0000-0002-9683-3407, Tan, AL orcid.org/0000-0002-9158-7243, McGonagle, D et al. (6 more authors) (2020) BSR Spondyloarthritis Course, 27 February 2020. Spondyloarthritis: pathogenesis, diagnosis and management. Rheumatology Advances in Practice, 4 (2). rkaa043. ISSN 2514-1775

De Marco, G orcid.org/0000-0003-2406-161X, Berekméri, A, Coates, LC et al. (12 more authors) (2020) Systematic literature review of non-topical treatments for early, untreated (systemic therapy naïve) psoriatic disease: a GRAPPA initiative. Rheumatology Advances in Practice. ISSN 2514-1775

Michelena, X, De Marco, G orcid.org/0000-0003-2406-161X, Dubash, S et al. (2 more authors) (2020) Comment on: Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis? Rheumatology. kez670. ISSN 1462-0324

Dubash, S, Marzo-Ortega, H and McGonagle, D (2019) Comment on: Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease: reply. Rheumatology. kez053. ISSN 1462-0324

Dubash, S, Bridgewood, C, McGonagle, D et al. (1 more author) (2019) The advent of IL-17A blockade in ankylosing spondylitis: secukinumab, ixekizumab and beyond. Expert Review of Clinical Immunology, 15 (2). pp. 123-134. ISSN 1744-666X

Dubash, S, Marianayagam, T, Tinazzi, I et al. (12 more authors) (2018) Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease. Rheumatology, Key 26. ISSN 1462-0324

Dubash, S, Pease, C, Aslam, A et al. (3 more authors) (2018) Acute Unilateral Sacroiliitis Mimicking Infection on Magnetic Resonance Imaging with Response to Nonsteroidal Antiinflammatory Drugs: A Distinct Presentation of Spondyloarthritis? The Journal of Rheumatology, 45. ISSN 0315-162X

Dubash, S, McGonagle, D and Marzo-Ortega, H (2018) New advances in the understanding and treatment of axial spondyloarthritis: from chance to choice. Therapeutic Advances in Chronic Disease, 9 (3). pp. 77-87. ISSN 2040-6223

Conference or Workshop Item

Dubash, S, Alabas, OA, Michelena, X et al. (7 more authors) (2021) Dactylitis is associated with greater disease severity, CRP, ultrasound determined synovitis, and erosive damage in DMARD-naïve early PsA. In: British Society for Rheumatology Annual Conference 2021, 26-28 Apr 2021, Virtual.

Dubash, S, Alabas, O, Michelena, X et al. (9 more authors) (2020) SAT0401 Swollen joints are associated with ultrasound power Doppler synovitis, whereas tender joints in the absence of swelling are not: an analysis of agreement and correlation in very early DMAR naïve Psoriatic arthritis. In: European League Against Rheumatism (EULAR) 2020, 03-06 Jun 2020, Online.

Dubash, S orcid.org/0000-0002-9303-7122, Alabas, O, Michelena, X et al. (8 more authors) (2020) SAT0413 Dactylitis is associated with disease severity and ultrasound defined erosive damage in very early, DMARD naïve Psoriatic arthritis. In: European League Against Rheumatism (EULAR) 2020, 03-06 Jun 2020, Online.

Michelena-Vegas, X, Dubash, S orcid.org/0000-0002-9303-7122, Morgan, A orcid.org/0000-0003-1109-624X et al. (1 more author) (2019) The prevalence of extra-articular manifestations in axial spondyloarthritis and psoriatic arthritis is associated to disease duration: results from the Leeds specialist spondyloarthritis service. In: Annual European Congress of Rheumatology (EULAR 2019), 12-15 Jun 2019, Madrid, Spain.

Dubash, S orcid.org/0000-0002-9303-7122, Bryer, D, Fitton, J et al. (4 more authors) (2018) Personalising care: using infliximab drug trough and anti-drug antibody levels improves clinical treatment decisions and is a cost effective strategy in spondyloarthritis. In: Annual European Congress of Rheumatology (EULAR 2018), 13-16 Jun 2018, Amsterdam, Netherlands.

Dubash, S orcid.org/0000-0002-9303-7122, Bryer, D, Fitton, J et al. (4 more authors) (2018) Personalising care: using infliximab drug trough and anti-drug antibody levels improves clinical treatment decisions and is a cost effective strategy in spondyloarthritis. In: Eleventh International Congress on Spondyloarthritides, 04-06 Oct 2018, Gent, Belgium.

Proceedings Paper

Dubash, S, Alabas, O, Michelena, X et al. (9 more authors) (2020) Swollen Joints but Not Tender Joints Are Associated with Ultrasound Power Doppler Synovitis in Very Early DMARD Naive Psoriatic Arthritis. In: Arthritis and Rheumatology. ACR Convergence 2020, 05-09 Nov 2020, Online. Wiley-Blackwell .

De Marco, G, Berekméri, A, Coates, LC et al. (10 more authors) (2019) Non Topical Pharmacological Treatment of Early, Untreated (DMARD-Naive, Systematic Therapy-Naive) Psoriatic Disease: a Systematic Review. In: Annals of the Rheumatic Diseases. EULAR 2019: Annual European Congress of Rheumatology, 12-15 Jun 2019, Madrid, Spain. BMJ Publishing Group , p. 904.